The Monkey Pox Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Monkey Pox Treatment market has seen a swift expansion in the recent past. The market size was $0.09 billion in 2024 and it is projected to increase to $0.1 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 13.6%.
The Monkey Pox Treatment market is anticipated to reach a size of $0.17 billion by the year 2029, expanding at a compound annual growth rate (CAGR) of 13.3%.
Download Your Free Sample of the 2025 Monkey Pox Treatment Market Report and Uncover Key Trends Now!The drivers in the monkey pox treatment market are:
• Outbreaks of monkey pox in endemic regions
• Increased awareness about zoonotic transmission
• Influence of smallpox eradication legacy
• Public health initiatives and human case emergence
The monkey pox treatment market covered in this report is segmented –
1) By Treatment Type: Prophylactic Vaccines, Therapeutics
2) By Dosage Forms: Solid, Liquid, Semi Solid
3) By Route Of Administration: Oral, Topical, Parenteral
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
The trends in the monkey pox treatment market are:
• Antiviral drug development is one of the key trends shaping the future of the monkey pox treatment market.
• The use of smallpox vaccines is steadily gaining ground and shaping market dynamics.
• The production and application of monoclonal antibodies is an important upcoming trend.
• Combination therapies and long-term immunity research are on the rise and will continue to shape the market's future.
The major players in the monkey pox treatment market are:
• Roche Holding AG
• Merck & Co
North America was the largest region in the monkey pox treatment market in 2023